Position in SCYX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,743
+$4,799 QoQ
Shares Held
12,959
+98.3% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 39 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $78,752,334 across 60 Drug Manufacturers - Specialty & Generic names. SCYX ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
193,067 | $13,873,794 | |
| 2 | VTRS |
Viatris Inc
|
630,996 | $10,020,216 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
13,055 | $7,073,590 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
204,521 | $5,033,261 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
27,124 | $4,571,478 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
117,664 | $4,079,410 | |
| 7 | PRGO |
PERRIGO Co plc
|
275,509 | $2,862,538 | |
| 8 | ALKS |
Alkermes plc.
|
50,788 | $2,661,291 |
All Filings in SCYX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,743 | 12,959 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $47,944 | 52,284 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $16,810 | 24,904 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $23,215 | 24,386 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $23,503 | 19,424 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,495 | 17,111 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $46,623 | 20,449 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||